SCHEMBL7675663

SCHEMBL7675663

CCCN1CN(Cc2ccccn2)c2cc(C(=O)OCC)ccc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 3/20 0.43
CNR2 P34972 1/20 0.43
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
MAPT P10636 3/20 0.42
LMNA P02545 1/20 0.42
GAA P10253 1/20 0.42
S1PR3 Q99500 5/20 0.41
PRMT1 Q99873 1/20 0.40
METAP1 P53582 1/20 0.40
DRD3 P35462 1/20 0.39
PABPC1 P11940 1/20 0.39
APOBEC3A P31941 1/20 0.39
EIF4H Q15056 1/20 0.39
APOBEC3G Q9HC16 1/20 0.39
MAPK1 P28482 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23918756 0.70 ALDH1A1 (0.51) ALDH1A1KDM4ENPC1RAB9AMEN1
SCHEMBL6170021 0.69 RAB9A (0.54) ALDH1A1KDM4ECNR2NPC1RAB9A
Hydrochloric Acid SCHEMBL18730111 0.69 DDB1 (0.50) ALDH1A1KDM4EMEN1KMT2ALMNA
SCHEMBL6171530 0.69 MEN1 (0.51) ALDH1A1CNR2NPC1RAB9AMEN1
SCHEMBL16827699 0.68 CREBBP (0.51) ALDH1A1KDM4ENPC1RAB9AMEN1
SCHEMBL3648379 0.67 PARP10 (0.66) ALDH1A1KDM4ENPC1RAB9AMAPT
SCHEMBL24604360 0.66 KDM5B (0.49) ALDH1A1KDM4ENPC1RAB9AMEN1
Hydrochloric Acid SCHEMBL10941122 0.66 ALDH1A1 (0.44) ALDH1A1KDM4ENPC1RAB9AMEN1
SCHEMBL14886589 0.66 TSHR (0.67) ALDH1A1KDM4ENPC1RAB9AMAPT
SCHEMBL10939620 0.65 ALDH1A1 (0.44) ALDH1A1KDM4ENPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6352985-B1 CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-03-05 US disclosed
US-6166219-A Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-12-26 US disclosed
EP-0882718-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-09 EP disclosed